Overview

A Randomized, Open-Label, Comparative, Parallel-Group, Multicenter Study of SPARC1507

Status:
Withdrawn
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
An open label study to determine the efficacy and safety of SPARC1507
Phase:
Phase 3
Details
Lead Sponsor:
Sun Pharma Advanced Research Company Limited